Cargando…
The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial
INTRODUCTION: Gabapentin, a neurotransmitter modulator, is thought to treat refractory cough associated with interstitial lung disease by improving cough hypersensitivity. METHODS/DESIGN: This is a single-center, prospective, randomized, double-blind, placebo-controlled trial. The trial will investi...
Autores principales: | Gao, Ronglin, Xu, Xianghuai, Wang, Shengyuan, Pu, Jincheng, Shi, Cuiqin, Wen, Siwan, Zhu, Yiqing, Tang, Jianping, Wang, Xuan, Yu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862465/ https://www.ncbi.nlm.nih.gov/pubmed/35189953 http://dx.doi.org/10.1186/s13063-022-06059-5 |
Ejemplares similares
-
A randomized, double-blinded, placebo-controlled clinical trial of duloxetine hydrochloride enteric-coated tablets in the treatment of refractory chronic cough
por: Wang, Shengyuan, et al.
Publicado: (2023) -
Diagnostic value of reflux episodes in gastroesophageal reflux-induced chronic cough: a novel predictive indicator
por: Wang, Shengyuan, et al.
Publicado: (2022) -
A Study on Cough Sensitivity and Airway Inflammation in Patients with Sinobronchial Syndrome
por: Wang, Shengyuan, et al.
Publicado: (2022) -
Psychological morbidity and chronic cough: which is predominant? A comparison of clinical characteristics
por: Zhang, Tongyangzi, et al.
Publicado: (2023) -
Cough hypersensitivity in patients with metabolic syndrome: a clinical finding and its possible mechanisms
por: Cheng, Jiafen, et al.
Publicado: (2021)